Alpha adrenergic antagonist: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
In [[pharmacology]], '''alpha adrenergic blockers''' are "drugs that bind to but do not activate alpha-adrenergic | In [[pharmacology]], '''alpha adrenergic blockers''' are "drugs that bind to but do not activate alpha-[[adrenergic receptor]]s thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of [[hypertension]], vasospasm, [[peripheral arterial disease|peripheral vascular disease]], [[shock]], and [[pheochromocytoma]]."<ref>{{MeSH}}</ref> They are also used for [[benign prostatic hyperplasia]]. | ||
Naftopidil is more selective for the alpha-1a [[adrenergic receptor]] and has been used to treat [[benign prostatic hyperplasia]].<ref name="pmid19821408">{{cite journal| author=Garimella PS, Fink HA, Macdonald R, Wilt TJ| title=Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. | journal=Cochrane Database Syst Rev | year= 2009 | volume= | issue= 4 | pages= CD007360 | pmid=19821408 | |||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=19821408 | doi=10.1002/14651858.CD007360.pub2 }} </ref> | |||
==Costs== | ==Costs== | ||
| Line 5: | Line 8: | ||
* [[Alfuzosin]] (Uroxatral) 10 mg - $121.85 for 30 tablets | * [[Alfuzosin]] (Uroxatral) 10 mg - $121.85 for 30 tablets | ||
* [[Doxasozin]] | * [[Doxasozin]] | ||
* [[Naftopidil]] | |||
* [[Prazosin]] (Minipress) 5 mg - $33.99 for ''60'' tablets | * [[Prazosin]] (Minipress) 5 mg - $33.99 for ''60'' tablets | ||
* [[Tamsulosin]] (Flomax) 0.4 - $142.19 for 30 tablets | * [[Tamsulosin]] (Flomax) 0.4 - $142.19 for 30 tablets | ||
Revision as of 11:48, 18 March 2010
In pharmacology, alpha adrenergic blockers are "drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma."[1] They are also used for benign prostatic hyperplasia.
Naftopidil is more selective for the alpha-1a adrenergic receptor and has been used to treat benign prostatic hyperplasia.[2]
Costs
According to drugstore.com:
- Alfuzosin (Uroxatral) 10 mg - $121.85 for 30 tablets
- Doxasozin
- Naftopidil
- Prazosin (Minipress) 5 mg - $33.99 for 60 tablets
- Tamsulosin (Flomax) 0.4 - $142.19 for 30 tablets
- Terazosin
References
- ↑ Anonymous (2024), Alpha adrenergic antagonist (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Garimella PS, Fink HA, Macdonald R, Wilt TJ (2009). "Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.". Cochrane Database Syst Rev (4): CD007360. DOI:10.1002/14651858.CD007360.pub2. PMID 19821408. Research Blogging.